Pulp Inflammatory Markers and Outcome of Pulpotomy
Launched by KING ABDULLAH UNIVERSITY HOSPITAL · May 5, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Dental caries is one of the most common chronic diseases of adults and children. If left untreated, the disease can have a wide range of dental, medical, social, and quality of life consequences, such as pain, infection, early tooth loss, and loss of self-confidence.
Full pulpotomy is a vital pulp therapy procedure that involves the removal of the coronal pulp to the levels of canal orifices followed by achieving hemostasis and placement of a biocompatible capping material. Full pulpotomy has been proved to be a promising alternative treatment option to the conventional root canal treatmen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non -contributory medical history (ASA 1)
- • Molar tooth with deep caries extending\>= 2/3 of dentine or exposing the pulp on the radiograph
- • The tooth should give positive response to cold sensibility testing
- • Clinical diagnosis of either reversible or irreversible pulpitis based on the symptoms and results of cold testing.
- • The tooth is restorable, probing pocket depth and mobility are within normal limits
- Exclusion Criteria:
- • Non-restorable tooth.
- • Signs of pulpal necrosis including sinus tract or swelling.
- • No enough bleeding after the pulpotomy procedure.
- • Inability to achieve hemostasis within 10 min after the pulpotomy.
About King Abdullah University Hospital
King Abdullah University Hospital (KAUH) is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Located in Jordan, KAUH is committed to enhancing medical knowledge and improving treatment outcomes by conducting rigorous clinical trials across various therapeutic areas. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals, ensuring the highest standards of research integrity and participant safety. Through its collaborative approach and focus on evidence-based medicine, KAUH aims to contribute significantly to the global medical community and the well-being of patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irbid, , Jordan
Patients applied
Trial Officials
Nessrin A Taha
Principal Investigator
Jordan University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported